Immunohistochemical study of stellate cells in patients with chronic viral hepatitis C genotype 1

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 1, 2011, Pages 137-143

  Sǎndulescu, Larisa ^a   Rogoveanu, I ^a   Ciurea, T ^a   Comǎnescu, Maria Victoria ^b   Streba, C T ^c   Ionescu, A G ^c   Oproaica, Alice ^c   Ene, M ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b Department of Pathology ^*  (Romania)

^c Ist Medical Clinic Gastroenterology Departmental Emergency Hospital   (Romania)

Author keywords

Chronic viral c hepatitis; Immunohistochemistry; Stellate cells

Indexed keywords

ACTIN;

ARTICLE; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SMOOTH MUSCLE; STELLATE CELL; VIROLOGY;

ACTINS; FEMALE; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH;

HEPATITIS C VIRUS;

EID: 79953046592     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Shaw-Stiffel T, Focus on hepatitis. Weight-based versus fixed-dose peginterferons, IAPAC Mon, 2004, 10 (5):178-180.
2. Kim WR, Global epidemiology and burden of hepatitis C, Microbes Infect, 2002, 4(12):1219-1225.
3. Esteban JI, Sauleda S, Quer J, The changing epidemiology of hepatitis C virus infection in Europe, J Hepatol, 2008, 48(1):148-162.
4. Gheorghe L, Iacob S, Csiki IE, Prevalence of hepatitis C in Romania: different from European rates?, J Hepatol, 2008, 49 (4):661-662; author reply 663.
5. Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D, Hepatitis C virusreplicating hepatocytes induce fibrogenic activation of hepatic stellate cells, Gastroenterology, 2005, 129(1):246-258.
6. The French METAVIR Cooperative Study Group, Intraobserver and interobserver variations in liver biopsy interprettation in patients with chronic hepatitis C, Hepatology, 1994, 20(1 Pt 1):15-20.
7. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander- Tetri BA, Bacon BR, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, 1999, 94(9):2467-2474.
8. Atzori L, Poli G, Perra A, Hepatic stellate cell: a star cell in the liver, Int J Biochem Cell Biol, 2009, 41(8-9):1639-1642.
9. Rogoveanu I, Sǎndulescu DL, Gheonea DI, Ciurea T, Comǎnescu V, Molecular bases of hepatic fibrogenesis - genetic and therapeutical implications in chronic viral C hepatitis, Rom J Morphol Embryol, 2008, 49(1):21-25.
10. Burt AD, Pathobiology of hepatic stellate cells, J Gastroenterol, 1999, 34(3):299-304.
11. Brenner DA, Waterboer T, Choi SK, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A, Rippe RA, New aspects of hepatic fibrosis, J Hepatol, 2000, 32(1 Suppl):32-38.
12. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T, Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers, J Hepatol, 2002, 36(2):200-209.
13. Tsukada S, Parsons CJ, Rippe RA, Mechanisms of liver fibrosis, Clin Chim Acta, 2006, 364(1-2):33-60.
14. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac- Sage P, Balabaud C, Desmoulière A, Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved, Int J Biochem Cell Biol, 2006, 38(2):135-151.
15. Baroni GS, Pastorelli A, Manzin A, Benedetti A, Marucci L, Solforosi L, Di Sario A, Brunelli E, Orlandi F, Clementi M, Macarri G, Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C, Liver, 1999, 19(3):212-219.
16. Khan MA, Poulos JE, Brunt EM, Li L, Solomon H, Britton RS, Bacon BR, Di Bisceglie AM, Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy, Hepatogastroenterology, 2001, 48(37):212-215.
17. Guido M, Rugge M, Chemello L, Leandro G, Fattovich G, Giustina G, Cassaro M, Alberti A, Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy, J Hepatol, 1996, 24(3):301-307.
18. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, Powell EE, Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation, J Hepatol, 2001, 34(2):314-320.
19. Chu CM, Shyu WC, Liaw YF, Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C, Dig Dis Sci, 2008, 53(5):1364-1369.
20. Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E, Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation, Dig Liver Dis, 2005, 37(5):349-356.
21. Tomanovic NR, Boricic IV, Brasanac DC, Stojsic ZM, Delic DS, Brmbolic BJ, Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study, J Gastrointest Liver Dis, 2009, 18(2):163-167.
22. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G, Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity, Hepatology, 2001, 33(6):1358-1364.
23. Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW, Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C, Liver Transpl, 2005, 11(10):1235-1241.
24. Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ, Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation, Liver Transpl, 2005, 11(10):1207-1213.